-
All Resources
(choose a category)
-
All Resources
-
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Injuries, accidents and wounds
- Learning disability
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Palliative care
- Patient experience
- Physical disability
- Public health
- Respiratory system
- Resource Type
-
Programme
- Cancer care improvement
- Cardiovascular disease
- Clinical engagement
- Early Years, Maternal and Reproductive Health
- Governance and assurance
- Inspection and regulation of healthcare services
- Long term conditions
- Mental health
- OPAH Tayside
- Patient experience
- Patient safety
- Primary care
- Programmes
- Technologies and medicines
- Year
-
St Margaret of Scotland Hospice unannounced independent healthcare inspection Jan 2013
- Published
- 14 January 2013
- Cycle of Improvement
- Scrutiny
-
Glasgow Royal Infirmary HAI Unannounced Inspection January 2013
- Published
- 09 January 2013
- Cycle of Improvement
- Scrutiny
-
Temporal artery thermometers: Technologies scoping report 11
- Published
- 20 December 2012
- Cycle of Improvement
- Evidence
-
Temporal artery thermometers: Advice Statement 011-12
- Published
- 20 December 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 268 - Ipililmumab for previously treated advanced (unresectable or metastatic) melanoma
- Published
- 12 December 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance No 270 – Leukaemia (acute myeloid ) – decitabine (terminated appraisal)
- Published
- 12 December 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 269 Vemurafenib for advanced or metastatic BRAF V600 mutation-positive malignant melanoma
- Published
- 11 December 2012
- Cycle of Improvement
- Evidence
-
Ninewells Hospital HAI unannounced inspection Dec 2012
- Published
- 10 December 2012
- Cycle of Improvement
- Scrutiny
-
Healthcare Improvement Scotland Research Strategy
- Published
- 06 December 2012
- Cycle of Improvement
- None
-
PROMs questionnaire user guide
- Published
- 05 December 2012
- Cycle of Improvement
- Improvement